Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2

Journal of Endocrinology

Volumn 158, Issue 3, 1998, Pages

  Ono, K ^a   Akatsu, T ^a   Murakami, T ^a   Nishikawa, M ^a   Yamamoto, M ^a   Kugai, N ^a   Motoyoshi, K ^a   Nagata, N ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; BUTAPROST; MESSENGER RNA; ONO AP 324 01; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; SULPROSTONE; UNCLASSIFIED DRUG; 11 DEOXYPROSTAGLANDIN E1; 11-DEOXYPROSTAGLANDIN E1; ANTIARRHYTHMIC AGENT; ANTIULCER AGENT; BIPHENYL DERIVATIVE; DRUG DERIVATIVE; PROSTAGLANDIN E; PROSTAGLANDIN E1; PROSTAGLANDIN E2 RECEPTOR, EP4 SUBTYPE;

ADOLESCENT; ANIMAL CELL; ARTICLE; BONE MARROW CELL; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CHEMICAL PHENOMENA; DRUG ANTAGONISM; DRUG POTENTIATION; GENETICS; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ALPROSTADIL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTI-ULCER AGENTS; BIPHENYL COMPOUNDS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; DEPRESSION, CHEMICAL; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; OSTEOCLASTS; POLYMERASE CHAIN REACTION; PROSTAGLANDINS E, SYNTHETIC; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER;

EID: 0031658957     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.158r001     Document Type: Article

References (30)

1. Akatsu T, Takahashi N, Debari K, Morita I, Murota S, Nagata N, Takatani O, Suda T 1989 Journal of Bone and Mineral Research 4 29-35.
2. Akatsu T, Takahashi N, Udagawa N, Imamura K, Yamaguchi A, Sato K, Nagata N, Suda T 1991 Journal of Bone and Mineral Research 6 183-189.
3. Burstone MS 1958 Journal of National Cancer Institute 21 523-539.
4. Coleman RA, Grix SP, Head SA, Loutitt JB, Mallet A, Sheldrick RLG 1994a Prostaglandins 47 151-168.
5. Coleman RA, Kennedy I, Humphrey PPA, Bunce K, Lumley P 1989 Prostanoids and their receptors. In Comprehensive Medical Chemistry vol 3, pp 643-714. Ed Hansch C. Oxford: Pergamon Press.
6. Coleman RA, Smith WL, Narumiya S 1994b Pharmacological Reviews 46 205-229.
7. Flanagan AM, Chambers TJ 1992 Endocrinology 130 443-448.
8. Harris M, Jenkins MV, Bennet A, Wills MR 1973 Nature 45 213-215.
9. Honda A, Sugimoto Y, Namba T, Watanabe A, Irie A, Negishi M, Narumiya S, Ichikawa A 1993 Journal of Biological Chemistry 268 7759-7762.
10. Jee WSS, Ueno K, Deng YP, Woodbury DM 1985 Calcified Tissue International 37 148-157.
11. Katsuyama M, Nishigaki N, Sugimoto Y, Morimoto K, Negishi M, Narumiya S, Ichikawa A 1995 FEBS Letters 372 151-156.
12. Kawaguchi H, Pilbeam CC, Harrison JR, Raisz LG 1995a Clinical Orthopedics and Related Research 313 36-46.
13. Kawaguchi H, Pilbeam CC, Vargas SJ, Morse E, Lorenzo JA, Raisz LG 1995b Journal of Clinical Investigation 96 539-548.
14. Koketsu M, Maruyama T, Yamamoto H, Kondo K, Aishita H 1996 Prostaglandins, Leukotrienes and Essential Fatty Acids 55, Suppl 1:142.
15. Koshihara Y, Kawamura M 1989 Biochemical Biophysical Research Communications 159 1206-1212.
16. Minkin C 1982 Calcified Tissue International 34 285-290.
17. Miyaura C, Kusano K, Masuzawa T, Chaki O, Onoe Y, Aoyagi M, Sasaki T, Tamura T, Koishihara Y, Ohsugi Y, Suda T 1995 Journal of Bone and Mineral Research 10 1365-1373.
18. Mundy GR, Roodman GD 1987 Osteoclast ontogeny and function. In Bone and Mineral Research, Annual 5, pp. 209-279. Ed Peck WA. Amsterdam: Elsevier Science Publishers.
19. Nishigaki N, Negishi M, Honda A, Sugimoto Y, Namba T, Narumiya S, Ichikawa A 1995 FEBS Letters 364 339-341.
20. Raisz LG, Martin TJ 1984 Prostaglandins in bone and mineral metabolism. In Bone and Mineral Research, Annual 2, pp. 286-310. Ed Peck WA. Amsterdam: Elsevier Science Publishers.
21. Reagan JW, Bailey TJ, Pepperl DJ, Pierce KL, Bogardus AM, Donello JE, Fairbairn CE, Kedzie KM, Woodward DF, Gil DW 1994 Molecular Pharmacology 46 213-220.
22. Ringel RE, Brenner JI, Haney PJ, Burn JE, Moulton AL, Berman MA 1982 Radiology 142 657-658.
23. Sato K, Fujii Y, Kasono K, Saji M, Tsushima T, Shizume K 1986 Biochemical and Biophysical Research Communications 138 618-624.
24. Sone K, Tashiro M, Fujinaga T, Tomomasa T, Tokugawa K, Kuroume T 1980 Journal of Pediatrics 97 866-867.
25. Suda M, Tanaka K, Natsui K, Utsui T, Tanaka I, Fukushima M, Shigeno C, Konishi J, Narumiya S, Ichikawa A, Nakao K 1996 Endocrinology 137 1698-1705.
26. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T 1988a Endocrinology 123 2600-2602.
27. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Boyde A, Suda T 1988b Endocrinology 122 1373-1382.
28. Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T 1989 Endocrinology 125 1805-1813.
29. Watabe A, Sugimoto Y, Honda A, Irie A, Namba T, Negishi M, Ito M, Narumiya S, Ichikawa A 1993 Journal of Biological Chemistry 268 20175-20178.
30. Yang R-S, Liu T-k, Shiau S-Y 1993 Calcified Tissue International 52 57-61.